BCIQ Profiles

Company Profile Report

KRAS inhibitor combinations for improved therapeutic efficacy


INDICATION: Lung cancer, pancreatic cancer

UCSF’s Kevan Shokat and colleagues have identified two sets of genes for which inhibition could improve the efficacy of KRAS G12C inhibitors. Through a CRISPR-based screen in human lung and pancreatic cancer cells treated with a KRAS G12C inhibitor tool compound for genes

Read the full 498 word article

How to gain access

Continue reading with a
two-week free trial.